<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mumby S</submitter><funding>Royal Brompton Hospital Charitable Fund</funding><funding>British Heart Foundation</funding><funding>Wellcome Trust Programme</funding><funding>European Respiratory Society Long-Term Fellowship</funding><funding>Imperial College London</funding><funding>National Funding Agency for Research</funding><funding>Wellcome Trust</funding><funding>NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton</funding><funding>Harefield NHS Foundation Trust</funding><pagination>157-164</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5215513</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Background and objective&lt;/h4>Nuclear factor kappa B (NF-kB)-mediated inflammatory gene expression and vascular endothelial cell proliferation/remodelling are implicated in the pathophysiology of the fatal disease, pulmonary arterial hypertension (PAH). Bromodomain and extra-terminal (BET) proteins are essential for the expression of a subset of NF-kB-induced inflammatory genes. BET mimics including JQ1+ prevent binding of BETs to acetylated histones and down-regulate the expression of selected genes.&lt;h4&gt;Methods&lt;/h4>The effects of JQ1+ on the proliferation of primary human pulmonary microvascular endothelial cells (HPMECs) from healthy subjects were measured by bromodeoxyuridine (BrdU) incorporation. Cell cycle progression was assessed by flow cytometry; mRNA and protein levels of cycli</pubmed_abstract><journal>Respirology (Carlton, Vic.)</journal><pubmed_title>Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension.</pubmed_title><pmcid>PMC5215513</pmcid><funding_grant_id>093080/Z/10/</funding_grant_id><funding_grant_id>093080/Z/10/Z</funding_grant_id><funding_grant_id>PG/14/27/30679</funding_grant_id><funding_grant_id>ANR-JSV1-001</funding_grant_id><pubmed_authors>Adcock IM</pubmed_authors><pubmed_authors>Meng C</pubmed_authors><pubmed_authors>Gambaryan N</pubmed_authors><pubmed_authors>Perros F</pubmed_authors><pubmed_authors>Mumby S</pubmed_authors><pubmed_authors>Humbert M</pubmed_authors><pubmed_authors>Wort SJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension.</name><description>&lt;h4>Background and objective&lt;/h4>Nuclear factor kappa B (NF-kB)-mediated inflammatory gene expression and vascular endothelial cell proliferation/remodelling are implicated in the pathophysiology of the fatal disease, pulmonary arterial hypertension (PAH). Bromodomain and extra-terminal (BET) proteins are essential for the expression of a subset of NF-kB-induced inflammatory genes. BET mimics including JQ1+ prevent binding of BETs to acetylated histones and down-regulate the expression of selected genes.&lt;h4&gt;Methods&lt;/h4>The effects of JQ1+ on the proliferation of primary human pulmonary microvascular endothelial cells (HPMECs) from healthy subjects were measured by bromodeoxyuridine (BrdU) incorporation. Cell cycle progression was assessed by flow cytometry; mRNA and protein levels of cycli</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jan</publication><modification>2025-04-05T14:13:17.951Z</modification><creation>2019-03-27T02:33:16Z</creation></dates><accession>S-EPMC5215513</accession><cross_references><pubmed>27539364</pubmed><doi>10.1111/resp.12872</doi></cross_references></HashMap>